Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF OPERATIONS

v3.8.0.1
CONDENSED STATEMENT OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating expenses:    
Research and development $ 9,439 $ 133
General and administration 986 371
Loss from operations (10,425) (504)
Interest income (48) 0
Interest expense 0 95
Interest expense - related party 0 61
Change in fair value of convertible notes payable 0 4
Change in fair value of warrant liabilities 0 (3)
Net Loss $ (10,377) $ (661)
Net loss per common share outstanding, basic and diluted $ (1.03) $ (0.22)
Weighted average number of common shares outstanding, basic and diluted 10,099,331 3,022,846